Search results for " RADIOTHERAPY"

showing 10 items of 156 documents

The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, B…

2011

Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the ne…

Continuous infusionComputer assisted radiotherapyFolic acidFluorodeoxyglucose f 18Gimeracil plus oteracil potassium plus tegafurInfection controlIntensity modulated radiation therapyDocetaxelCancer stagingMetastatic gastric cancerRisk FactorsPrevalenceDrug fatalityOverall survivalNeoplasm MetastasisPriority journalddc:616Conference paperdigestive oral and skin physiologyFolinic acidHematologyPrognosisOxaliplatinNuclear magnetic resonance imagingBevacizumabSurvival RateOncologyCyanocobalaminPractice Guidelines as TopicDrug dose reductionFluorouracilEsophageal adenocarcinomaHumanPositron emission tomographymedicine.medical_specialtyNeutropeniaStomach cancerStomach neoplasmsMEDLINESide effectStomach adenocarcinomaPatient careIrinotecanHelicobacter infectionPrimary tumorEndoscopic echographyAdvanced cancerEndoscopic mucosal resectionComputer assisted tomographyStomach Neoplasms/*diagnosis/pathology/*therapymedicineHumansGenetic Predisposition to DiseaseGastrointestinal cancerPhase 3 clinical trial (topic)Intensive care medicineSurvival ratePlaceboCapecitabineEpirubicinCa 19-9 antigenStomach Neoplasms/diagnosis/pathology/therapyHelicobacter pyloribusiness.industryCancerTrastuzumabCardiovascular riskmedicine.diseaseCancer susceptibilitydigestive system diseasesSurgeryClinical trialMetastasis potentialExpert opinionMeta analysis (topic)Cancer adjuvant therapyCarcinoembryonic antigenLower esophagus sphincterCisplatinCaloric intakebusinessCancer incidenceRegional differencesAnnals of Oncology
researchProduct

9 Development of an experimental tool to evaluate normal tissue 3D doses in external-beam radiotherapy

2018

Introduction Recently, cancer treatment improvement enabled an increase in patients’ survival rate. In more than half of the cases, radiotherapy participates in the cure for cancer. The efficacy of this technique is well known but it inevitably delivers doses to normal tissues exposing them to radio-induced complications risks [1] . Moreover, the longer patients’ life expectancy increases the risk of developing long-term complications such as second cancers. Thus, evaluating the risks following cancer treatment involving radiotherapy constitutes a major challenge. In this context, an experimental tool has been developed to evaluate normal tissue doses delivered by the different radiotherapy…

Contouringbusiness.industrymedicine.medical_treatmentBiophysicsGeneral Physics and AstronomyDose profileContext (language use)General MedicineGel dosimetryImaging phantom030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePlanned Dose030220 oncology & carcinogenesismedicineRadiology Nuclear Medicine and imagingExternal beam radiotherapyNuclear medicinebusinessRadiation treatment planningPhysica Medica
researchProduct

Male breast cancer.

2010

Male breast cancer (MaleBC) is a rare disease, accounting for <1% of all male tumors. During the last few years, there has been an increase in the incidence of this disease, along with the increase in female breast cancer (FBC). Little is known about the etiology of MaleBC: hormonal, environmental and genetic factors have been reported to be involved in its pathogenesis. Major risk factors include clinical disorders carrying hormonal imbalances, radiation exposure and, in particular, a positive family history (FH) for BC, the latter suggestive of genetic susceptibility. Rare mutations in high-penetrance genes (BRCA1 and BRCA2) confer a high risk of BC development; low-penetrance gene mutati…

CounselingMalemedicine.medical_specialtymedicine.medical_treatmentchemotherapyHyperestrogenismsurvivalBreast Neoplasms MalesurgeryBreast cancerRisk Factorspolycyclic compoundsmedicineHumansgeneticsFamily historyskin and connective tissue diseaseshormonal treatmentneoplasmsradiotherapyGynecologytherapybusiness.industryCarcinomaCancerHematologybacterial infections and mycosesmedicine.diseasePrognosisMale breast cancergenetics; hormonal treatment; male breast cancer; survival; local recurrence; radiotherapy; therapy; surgery; chemotherapyRadiation therapyOncologyMale breast cancerbacteriaFemaleBreast diseaselocal recurrencemedicine.symptombusinessAlgorithmsRare disease
researchProduct

MR-Mammographie zur Responsekontrolle bei primärer Chemobrachytherapie des BET-inoperablen Mammakarzinoms

2001

Ziel: Evaluierung (1) moglicher storender Effekte neoadjuvanter Chemobrachytherapie auf die MR-Mammographie, (2) der Eignung der MRM zur Bestimmung der Resttumorgrose nach Therapie und (3) der Eignung der MRM zur Prognose des Gesamtansprechens nach den ersten Therapiezyklen. Methoden: 14 Patientinnen, die an einer praoperativen Tumorreduktionstherapie (4 Zyklen Chemotherapie kombiniert mit interstitieller Radiotherapie) teilnahmen, wurden mittels dynamischer MR-Mammographie (1 T, zeitliche Auflosung 93 s, raumliche Auflosung 1,9 mm, 0,1 mmol/kg GdDTPA) vor Therapie, nach den ersten beiden Chemotherapiezyklen, nach der Radiotherapie und dem dritten Zyklus sowie nach Therapieabschluss untersu…

End of therapybusiness.industrymedicine.medical_treatmentSingle tumorComplete remissionTumor responseRadiation therapyInterstitial radiotherapyMedicineRadiology Nuclear Medicine and imagingbusinessNuclear medicineNeoadjuvant therapyMr mammographyRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

First Characterization of Novel Silicon Carbide Detectors with Ultra-High Dose Rate Electron Beams for FLASH Radiotherapy

2023

Ultra-high dose rate (UHDR) beams for FLASH radiotherapy present significant dosimetric challenges. Although novel approaches for decreasing or correcting ion recombination in ionization chambers are being proposed, applicability of ionimetric dosimetry to UHDR beams is still under investigation. Solid-state sensors have been recently investigated as a valuable alternative for real-time measurements, especially for relative dosimetry and beam monitoring. Among them, Silicon Carbide (SiC) represents a very promising candidate, compromising between the maturity of Silicon and the robustness of diamond. Its features allow for large area sensors and high electric fields, required to avoid ion r…

FLASH radiotherapy; Silicon Carbide; dosimetry; beam monitoring; UHDRFluid Flow and Transfer Processesbeam monitoringdosimetrySilicon CarbidePhysicsProcess Chemistry and TechnologyGeneral EngineeringSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Computer Science ApplicationsChemistryUHDRFLASH radiotherapyGeneral Materials ScienceHuman medicineInstrumentationApplied Sciences (Switzerland)
researchProduct

Electronic Design for a Bleeding Detector to be Used in Intraoperative Radiotherapy Applications

2021

An electronic design for a bleeding detector used with mobile linac during intraoperative radiotherapy (IORT) is presented. It consists on a readout circuit based on a De Sauty Bridge and a wireless power supply using a supercapacitor. The goal is the measurement of the height of fluid present in the applicator in order to avoid a misadministration dose during the irradiation process. A minimum measurement height of 5 mm is required by clinic to be confident with the selected radiation dose. The measurement circuit uses a capacitive sensor which detects variations lower than 0.1 pF. The readout circuit converts dynamic capacitance variation from the bleeding detector into an analog voltage …

FluidsMaterials scienceIntraoperative radiotherapybleeding detectorCapacitive sensingDetectorDe Sauty bridgecapacitive sensorLinearityCapacitive sensorsDetectorsRepeatabilityApplicatorsmobile linacsCapacitanceSignalLinear particle acceleratorBridge circuitswireless supplyElectrical and Electronic EngineeringHemorrhagingInstrumentationVoltageBiomedical engineering
researchProduct

High resistance to X-rays and therapeutic carbon ions in glioblastoma cells bearing dysfunctional ATM associates with intrinsic chromosomal instabili…

2014

To investigate chromosomal instability and radiation response mechanisms in glioblastoma cells.We undertook a comparative analysis of two patient-derived glioblastoma cell lines. Their resistance to low and high linear energy transfer (LET) radiation was assessed using clonogenic survival assay and their intrinsic chromosome instability status using fluorescence in situ hybridization. DNA damage was analyzed by pulsed-field gel electrophoresis and by γ-H2AX foci quantification. Expression of DNA damage response proteins was assessed by immunoblot.Increased radioresistance to X-rays as well as carbon ions was observed in glioblastoma cells exhibiting high levels of naturally occurring chromo…

Genome instabilityDNA RepairDNA damageLinear energy transferHeavy Ion RadiotherapyAtaxia Telangiectasia Mutated ProteinsBiologyRadiation ToleranceCell Line TumorChromosomal InstabilityRadioresistanceChromosome instabilitymedicineHumansDNA Breaks Double-StrandedLinear Energy TransferRadiology Nuclear Medicine and imagingGel electrophoresisRadiological and Ultrasound Technologymedicine.diagnostic_testX-RaysCell CycleGenomicsMolecular biologyPhosphorylationGlioblastomaSignal TransductionFluorescence in situ hybridizationInternational Journal of Radiation Biology
researchProduct

EGFR tyrosine kinase inhibitor therapy continuation with high-dose hypofractionated radiotherapy in EGFR-mutated non-small cell lung cancer (NSCLC) p…

2020

e21580 Background: EGFR tyrosine kinase inhibitors (TKIs) represent the standard first-line therapy for advanced non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, despite initial marked responses, tumors invariably develop acquired resistance to TKIs. Oligoprogression is commonly observed during treatment with oncogene-directed therapies, including EGFR TKIs, and refers to patients who experience disease progression only in limited sites as a result of heterogeneous mechanisms of resistance. The use of local ablative treatments for these resistant lesions may extend the duration of TKI therapy and potentially improve long-term disease control and survival…

Hypofractionated RadiotherapyCancer Researchbusiness.industrynon-small cell lung cancer (NSCLC)Diseasemedicine.diseaseEGFR Tyrosine Kinase Inhibitor TherapyEGFR Tyrosine Kinase Inhibitorsrespiratory tract diseasesOncologyEgfr mutationCancer researchMedicineNon small cellbusinessJournal of Clinical Oncology
researchProduct

Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study.

2019

Objective: To report preliminary findings of a phase II study exploring the clinical outcomes of moderate hypofractionated radiotherapy performed with helical tomotherapy (HT) using computed tomography–magnetic resonance imaging–based planning for localized prostate cancer. Methods: The phase II prospective study received ethics approval from our institutional ethics committee. A dose of 60 Gy/20 fractions for low–intermediate risk prostate cancer by means of HT was explored. Primary endpoints of the study were acute and late gastrointestinal (GI) and genitourinary (GU) toxicities. Secondary endpoints were quality of life and biochemical-free survival. Results: A total of 35 patients were i…

Hypofractionated RadiotherapyMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmenttomotherapyPhases of clinical researchTomotherapy030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicinePreliminary reportProstatemedicineBiomarkers TumorHumansProspective StudiesNeoplasm MetastasisProspective cohort studyRadiometryProstate hypofractionation tomotherapyAgedNeoplasm StagingAged 80 and overhypofractionationbusiness.industryRadiotherapy Planning Computer-AssistedProstateProstatic NeoplasmsGeneral MedicineMiddle Agedmedicine.diseasehypofractionation; Prostate; tomotherapymedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisQuality of LifeObservational studyRadiation Dose HypofractionationRadiologyRadiotherapy Intensity-ModulatedbusinessFollow-Up StudiesTumori
researchProduct

Detector for monitoring potential bleeding during electron intraoperative radiotherapy

2018

Purpose: The aim of this work is to develop a bleeding detector integrated into the acrylic circular applicators for specific mobile linacs. Thus, a bleeding detector has been developed based on a capacitive sensor to be used with plastic applicators, as in the case of LIAC HWL from Sordina IORT Technologies SpA. According to the clinical impact, we have selected 0.5 cm as the minimum depth of fluid that should be detected. Methods: An experiment was developed using water-simulating blood. Two setups were considered: non-beveled applicators with 7 cm and 10 cm diameter. Measurements were done for applicators 0 degrees and 45 degrees tilted, both with respect to the horizontal surface, in or…

Intraoperative radiotherapyMaterials scienceCapacitive sensingBiophysicsPhase (waves)General Physics and AstronomyElectronsHemorrhageRadiation030218 nuclear medicine & medical imagingIntraoperative Period03 medical and health sciences0302 clinical medicineOpticsRadiology Nuclear Medicine and imagingIrradiationRadiation InjuriesRadiotherapybusiness.industryBleedingContinuous monitoringDetectorLinearityGeneral MedicineBevel030220 oncology & carcinogenesisCapacitive sensorParticle AcceleratorsbusinessPhysica Medica
researchProduct